Watching Parkinson's disease with wrist-based sensors.
NPJ Digit Med
; 5(1): 73, 2022 Jun 13.
Article
em En
| MEDLINE
| ID: mdl-35697864
Parkinson's disease (PD) lacks sensitive, objective, and reliable measures for disease progression and response. This presents a challenge for clinical trials given the multifaceted and fluctuating nature of PD symptoms. Innovations in digital health and wearable sensors promise to more precisely measure aspects of patient function and well-being. Beyond research trials, digital biomarkers and clinical outcome assessments may someday support clinician-initiated or closed-loop treatment adjustments. A recent study from Verily Life Sciences presents results for a smartwatch-based motor exam intended to accelerate the development and evaluation of therapies for PD.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
NPJ Digit Med
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Estados Unidos